Study #2024-1172
Prospective study evaluating the treatment outcomes for localised recurrent, resectable retroperitoneal liposarcoma (ReLaPSe)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Prospective study evaluating the treatment outcomes for resectable retroperitoneal liposarcoma
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Soft Tissue
Study phase:
Not applicable
Physician name:
Christina Roland
Department:
Surgical Oncology
For general questions about clinical trials:
1-833-670-2212
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.